Literature DB >> 9440622

Fas antigen expression of hepatocytes and its modification by immunosuppressants.

I Yokoyama1, A Hayakawa, S Hayashi, T Kobayashi, M Negita, H Takagi.   

Abstract

Active cell death induced by ligation of the Fas antigen (Fas-Ag) with its antibody, Fas ligand (Fas-L), has been known to play a major role in cell killing via apoptosis by cytotoxic T lymphocytes (CTL). Thus, in liver transplantation, Fas-Ag expression of hepatocytes and its modification by immunosuppressive agents such as FK 506 or CsA can theoretically influence allograft survival. Mouse hepatocytes (BALB/c) were isolated and cultured with or without FK 506 or CsA, and Fas-Ag expression was determined by flow cytometry. Fas-Ag expression in the control was 17.2 +/- 2.5% after 24 hr of culture. When FK 506 or CsA was added, Fas-Ag expression with FK 506 at a concentration of 0.01-0.1 microg/ml was significantly lower than that with CsA (P < 0.05). When the cells were incubated with apoptosis-inducing anti-Fas-Ag monoclonal antibody, agarose gel electrophoresis of the control cells yielded a typical pattern of DNA fragmentations. The cells with FK 506 at 0.01 microg/ml yielded the least DNA fragmentation. These findings suggested that in the in vivo setting, the hepatocytes of the allograft would have a lower chance of being attacked by CTL in the host treated with FK 506.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9440622     DOI: 10.1023/a:1018848108977

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness.

Authors:  L B Owen-Schaub; R Radinsky; E Kruzel; K Berry; S Yonehara
Journal:  Cancer Res       Date:  1994-03-15       Impact factor: 12.701

Review 2.  Role of Ca2+ in toxic cell killing.

Authors:  S Orrenius; D J McConkey; G Bellomo; P Nicotera
Journal:  Trends Pharmacol Sci       Date:  1989-07       Impact factor: 14.819

3.  Lethal effect of the anti-Fas antibody in mice.

Authors:  J Ogasawara; R Watanabe-Fukunaga; M Adachi; A Matsuzawa; T Kasugai; Y Kitamura; N Itoh; T Suda; S Nagata
Journal:  Nature       Date:  1993-08-26       Impact factor: 49.962

4.  Apoptosis is induced by transforming growth factor-beta 1 within 5 hours in regressing liver without significant fragmentation of the DNA.

Authors:  F Oberhammer; W Bursch; R Tiefenbacher; G Fröschl; M Pavelka; T Purchio; R Schulte-Hermann
Journal:  Hepatology       Date:  1993-11       Impact factor: 17.425

5.  Cyclosporine and FK506 inhibition of murine mast cell cytokine production.

Authors:  S M Hatfield; N W Roehm
Journal:  J Pharmacol Exp Ther       Date:  1992-02       Impact factor: 4.030

6.  Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis.

Authors:  C M Eischen; C J Dick; P J Leibson
Journal:  J Immunol       Date:  1994-09-01       Impact factor: 5.422

7.  Expression and function of mouse Fas antigen on immature and mature T cells.

Authors:  Y Nishimura; A Ishii; Y Kobayashi; Y Yamasaki; S Yonehara
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

8.  Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group.

Authors: 
Journal:  Lancet       Date:  1994-08-13       Impact factor: 79.321

9.  Fas transduces activation signals in normal human T lymphocytes.

Authors:  M R Alderson; R J Armitage; E Maraskovsky; T W Tough; E Roux; K Schooley; F Ramsdell; D H Lynch
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

Review 10.  Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.

Authors:  J F Kerr; A H Wyllie; A R Currie
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640

View more
  1 in total

Review 1.  The role of tacrolimus in inflammatory bowel disease: a systematic review.

Authors:  Yago Gonzalez-Lama; Javier P Gisbert; Jose Mate
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.